We are live on
!
Find out more
TAM
Taurus Asset Management Portfolio holdings
AUM
$986M
1-Year Est. Return
5.04%
This Fund
S&P 500
This Quarter
Est. Return
+4.13%
1 Year Est. Return
+5.04%
3 Year Est. Return
+26.94%
5 Year Est. Return
+134.98%
10 Year Est. Return
+234.84%
AUM
$638M
AUM Growth
+$29M
(+4.8%)
Cap. Flow
+$5.25M
Cap. Flow
% of AUM
0.82%
Top 10 Holdings %
Top 10 Hldgs %
32.99%
Holding
102
New
9
Increased
15
Reduced
51
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$11.7M |
| 2 |
FMC
FMC
|
+$9.26M |
| 3 |
GRA
W.R. Grace & Co.
GRA
|
+$7.8M |
| 4 |
JPMorgan Chase
JPM
|
+$4.67M |
| 5 |
Air Products & Chemicals
APD
|
+$3.59M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.26M |
| 2 |
Restaurant Brands International
QSR
|
+$5.89M |
| 3 |
Intuit
INTU
|
+$5.66M |
| 4 |
Newell Brands
NWL
|
+$5.1M |
| 5 |
WFM
Whole Foods Market Inc
WFM
|
+$4.86M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.24% |
| 2 | Consumer Discretionary | 15.14% |
| 3 | Consumer Staples | 14.84% |
| 4 | Technology | 12.51% |
| 5 | Financials | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Boston Scientific
BSX
$71.5B
| $10.8M | 1.69% |
388,850
-100
| -0% | -$2.65K |
|
27
3M
MMM
$94.3B
| $10.7M | 1.68% |
61,730
-1,083
| -2% | -$181K |
|
28
Visa
V
$677B
| $10.3M | 1.61% |
109,735
-125
| -0.1% | -$11.6K |
|
29
Occidental Petroleum
OXY
$55.9B
| $10.2M | 1.6% |
170,080
+3,010
| +2% | +$184K |
|
30
Fortive
FTV
$18.6B
| $9.44M | 1.48% |
236,182
-305
| -0.1% | -$12K |
|
31
LKQ Corp
LKQ
$6.29B
| $9.23M | 1.45% |
280,010
+5,225
| +2% | +$162K |
|
|
32
FMC
FMC
$1.33B
| $9.12M | 1.43% |
+143,877
| New | +$9.26M |
|
33
Altria Group
MO
$114B
| $9.11M | 1.43% |
122,285
-800
| -0.6% | -$58.5K |
|
34
Johnson & Johnson
JNJ
$625B
| $9.03M | 1.41% |
68,242
-1,320
| -2% | -$168K |
|
35
Goldman Sachs
GS
$303B
| $8.87M | 1.39% |
39,989
+965
| +2% | +$214K |
|
36
RTX Corp
RTX
$301B
| $8.81M | 1.38% |
114,638
-51,149
| -31% | -$3.83M |
|
37
Pentair
PNR
$11B
| $8.7M | 1.36% |
194,709
| – | – |
|
38
Cooper Companies
COO
$14.5B
| $8.53M | 1.34% |
142,560
-3,300
| -2% | -$179K |
|
39
Starbucks
SBUX
$120B
| $8.17M | 1.28% |
140,090
-100
| -0.1% | -$6.05K |
|
|
GRA
40
DELISTED
W.R. Grace & Co.
GRA
| $8.01M | 1.25% |
+111,230
| New | +$7.8M |
|
41
GE Aerospace
GE
$384B
| $7.7M | 1.21% |
59,490
-4,354
| -7% | -$597K |
|
42
Oracle
ORCL
$423B
| $7.66M | 1.2% |
152,717
-2,660
| -2% | -$121K |
|
43
ExxonMobil
XOM
$634B
| $7.52M | 1.18% |
93,125
-3,315
| -3% | -$271K |
|
|
44
Newell Brands
NWL
$2.56B
| $7.14M | 1.12% |
133,130
-100,595
| -43% | -$5.1M |
|
45
Procter & Gamble
PG
$339B
| $6.51M | 1.02% |
74,666
-2,915
| -4% | -$257K |
|
|
TWX
46
DELISTED
Time Warner Inc
TWX
| $5.61M | 0.88% |
55,890
-9,155
| -14% | -$907K |
|
47
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $5.46M | 0.86% |
22,603
-875
| -4% | -$210K |
|
48
AbbVie
ABBV
$435B
| $4.17M | 0.65% |
57,452
-300
| -0.5% | -$20.2K |
|
49
American Express
AXP
$230B
| $3.31M | 0.52% |
39,276
-3,125
| -7% | -$247K |
|
50
Chevron
CVX
$366B
| $3.29M | 0.52% |
31,554
-2,425
| -7% | -$257K |
|
Similar funds
CHP
CIG
CCM
LC
SBIA
WCF
SWC
KTA
Taurus Asset Management's Q2 2017 Portfolio in Review
As of Q2 2017, Taurus Asset Management held 102 positions worth $638M, up 4.8% from $609M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Taurus Asset Management's Q2 2017 filing shows 9 new, 15 increased, 51 reduced and 4 closed positions. Its largest new stake was Analog Devices: 147,535 shares worth $11.5M. The largest sale was Bristol-Myers Squibb, an estimated $6.26M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
- Taurus Asset Management's largest Q2 2017 buy was Analog Devices: 147,535 shares worth $11.5M.
- Taurus Asset Management added most to JPMorgan Chase in Q2 2017, an estimated $4.67M increase.
- Taurus Asset Management's biggest Q2 2017 reduction was Restaurant Brands International, cutting an estimated $5.89M.
- Taurus Asset Management fully exited Bristol-Myers Squibb in Q2 2017, selling an estimated $6.26M.
- Taurus Asset Management's ten largest holdings make up 33% of its $638M portfolio in Q2 2017.
- Taurus Asset Management opened 9 new positions and closed 4 in Q2 2017.
- Taurus Asset Management's portfolio value rose 4.8% quarter-over-quarter to $638M.
Based on Taurus Asset Management's 13F filing for Q2 2017, filed 3 Aug 2017.